![Rick Schnellman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rick Schnellman
Oprichter bij Rediscovery Life Sciences LLC
Oorsprong van het eerstegraads netwerk van Rick Schnellman
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Rediscovery Life Sciences LLC
![]() Rediscovery Life Sciences LLC BiotechnologyHealth Technology Rediscovery Life Sciences LLC operates as a clinical-stage biotechnology company that focuses to develop suramin in acute kidney injury. The company was founded by Rick Schnellman and is headquartered in Charleston, SC.
5
| Holding Company | Biotechnology | 5 |
Rediscovery Life Sciences AKI LLC
![]() Rediscovery Life Sciences AKI LLC Medical/Nursing ServicesHealth Services Rediscovery Life Sciences AKI LLC engages in the development of treatments with less risk through drug repurposing. The company is headquartered in Charleston, SC.
5
| Subsidiary | Medical/Nursing Services | 5 |
Mitochem Therapeutics, Inc.
![]() Mitochem Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Mitochem Therapeutics, Inc. is a privately held company based in Charleston, SC that develops therapies for diseases involving mitochondrial dysfunction. Mitochem Therapeutics has a proprietary library of mitochondrial protective compounds, and early proof of concept in numerous in vivo models for retinitis pigmentosa (RP) and age-related macular degeneration (AMD). The lead compound MC16 is a first-in-class small molecule that up-regulates pro-survival and anti-oxidant pathways. In 2021, the Food and Drug Administration (FDA) granted orphan drug designation status to MC16 for the treatment of RP. The company is pursuing partnerships to develop non-ophthalmic indications such as Parkinson's, Alzheimer's, ALS, muscular dystrophies, diabetes, ischemias, and kidney diseases. The company was founded by Bärbel Rohrer and Craig C. Beeson to develop a new approach to treating neurodegeneration and aging diseases by protecting mitochondrial homeostasis. The CEO is Michael Voevodsky.
3
| Holding Company | Pharmaceuticals: Generic | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rick Schnellman via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
The Quaker Oats Co.
![]() The Quaker Oats Co. Beverages: Non-AlcoholicConsumer Non-Durables The Quaker Oats Co. manufactures beverages and other food products. It also manufactures bottled and canned soft drinks, granola bars and clusters, flour and flour mixes from purchased flour, rice cakes, cereals and uncooked rice products. The company was founded in 1877 and is headquartered in Chicago, IL. | Beverages: Non-Alcoholic | Corporate Officer/Principal | |
Matrixx Initiatives, Inc.
![]() Matrixx Initiatives, Inc. Pharmaceuticals: MajorHealth Technology Matrixx Initiatives, Inc. manufactures and distributes over-the-counter cold remedy and allergy products. It offers homeopathic and allopathic OTC products, including cold remedy nasal spray and swab, allergy relief spray and swab, kids cold remedy relief, nasal congestion/sinus relief, cold shortening, dietary supplement line, and total immune products. The firm's products include Rapidmelts, Crystals, Lozenges, Oral Mist, Chewables, Intense Sinus Relief and Allergy Relief. The company was founded on February 4, 1991 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
PRA HEALTH SCIENCES, INC. | Miscellaneous Commercial Services | President | |
University of Notre Dame | College/University | Undergraduate Degree | |
Salutaris Medical Devices, Inc.
![]() Salutaris Medical Devices, Inc. Medical SpecialtiesHealth Technology Salutaris Medical Devices, Inc. operates as a clinical-stage medical device company. It develops minimally invasive, patient-centric treatments. The firm also develops an investigational ophthalmic treatment for Wet Age-related Macular Degeneration (Wet AMD). The company was founded by Russell J. Hamilton and Laurence J. Marsteller in 2008 and is headquartered in Tucson, AZ. | Medical Specialties | Chief Executive Officer | |
University of Missouri | College/University | Undergraduate Degree | |
North Carolina State University | College/University | Undergraduate Degree | |
The Pennsylvania State University | College/University | Masters Business Admin | |
University of Arizona | College/University | Undergraduate Degree | |
Council for Entrepreneurial Development
![]() Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Rex Health Ventures LLC
![]() Rex Health Ventures LLC Investment ManagersFinance Rex Health Ventures LLC (Rex Health Ventures) is a venture capital subsidiary of Rex Strategic Innovations founded in 2012. The firm is headquartered in Raleigh, North Carolina. | Investment Managers | Private Equity Investor | |
Vascular Pharmaceuticals, Inc.
![]() Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard Business School | College/University | Masters Business Admin | |
The Fuqua School of Business | College/University | Masters Business Admin | |
UNC School of Law | College/University | Undergraduate Degree | |
KCBN Holding, Inc.
![]() KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Miscellaneous | Director/Board Member | |
Evolution Research Group LLC
![]() Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Advarra, Inc.
![]() Advarra, Inc. Miscellaneous Commercial ServicesCommercial Services Advarra, Inc. engages in the provision of integrated research compliance solutions. It offers institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services. It also covers GxP/GCP auditing and compliance, regulatory, clinical quality and assurance, research administration and human research protection (HRP), and data protection and technology compliance. The company was founded in 1983 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Basking Biosciences, Inc.
![]() Basking Biosciences, Inc. BiotechnologyHealth Technology Basking Biosciences, Inc. is a clinical-stage company that aims to solve the biggest need in ischemic stroke therapy. The company is based in Columbus, OH. The company is developing a first-in-class RNA aptamer targeting von Willebrand factor (vWF), an important structural component of blood clots and driver of the clotting process. Basking is also developing a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing the pharmacological activity of the RNA aptamer. The company has successfully completed a phase 1 single-ascending dose safety study and is initiating a phase 2 clinical proof-of-concept study in patients suffering from an acute ischemic stroke. The ultimate goal is to extend the therapeutic window for thrombolysis compared to currently approved therapies. Basking Biosciences was founded in 2019 by Shahid Nimjee, Bruce A. Sullenger, and Richard J. Shea has been the CEO of the company since 2019. | Biotechnology | Chief Executive Officer | |
University of North Carolina at Chapel Hill | College/University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 25 |
Sectoraal
Consumer Services | 10 |
Commercial Services | 7 |
Health Technology | 6 |
Consumer Non-Durables | 3 |
Finance | 3 |
Operationeel
Director/Board Member | 16 |
Chief Executive Officer | 9 |
Undergraduate Degree | 5 |
Corporate Officer/Principal | 4 |
Chairman | 4 |
Sterkste connecties
- Beurs
- Insiders
- Rick Schnellman
- Bedrijfsconnecties